Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 197

Cited In for PubMed (Select 9806549)

1.

Peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and colorectal cancer (CRC) risk.

Wang W, Shao Y, Tang S, Cheng X, Lian H, Qin C.

Int J Clin Exp Med. 2015 Mar 15;8(3):4066-72. eCollection 2015.

2.

Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-Analysis.

Wei Z, Han G, Bai X.

Med Sci Monit. 2015 Jun 2;21:1611-6. doi: 10.12659/MSM.892849.

PMID:
26049557
3.

Effect of the PPARG2 Pro12Ala Polymorphism on Associations of Physical Activity and Sedentary Time with Markers of Insulin Sensitivity in Those with an Elevated Risk of Type 2 Diabetes.

Yates T, Davies MJ, Henson J, Edwardson C, Webb D, Bodicoat DH, Webb M, Howard P, Cooper JA, Humphries SE, Khunti K, Talmud P.

PLoS One. 2015 May 14;10(5):e0124062. doi: 10.1371/journal.pone.0124062. eCollection 2015.

4.

The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes.

Lapice E, Monticelli A, Cocozza S, Pinelli M, Cocozza S, Bruzzese D, Riccardi G, Vaccaro O.

J Transl Med. 2015 Mar 12;13:85. doi: 10.1186/s12967-015-0448-6.

5.

An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndrome.

Ali O, Cerjak D, Kent JW Jr, James R, Blangero J, Carless MA, Zhang Y.

Clin Epigenetics. 2015 Feb 20;7(1):12. doi: 10.1186/s13148-015-0048-6. eCollection 2015.

6.

Sequence variants of peroxisome proliferator-activated receptor-gamma gene and the clinical courses of patients with end-stage renal disease.

Chao CT, Chen YC, Chiang CK, Huang JW, Hu FC, Fang CC, Chang CC, Yen CJ.

Dis Markers. 2015;2015:763459. doi: 10.1155/2015/763459. Epub 2015 Feb 15.

7.

Genetics of type 2 diabetes-pitfalls and possibilities.

Prasad RB, Groop L.

Genes (Basel). 2015 Mar 12;6(1):87-123. doi: 10.3390/genes6010087. Review.

8.

Polymorphism of FABP2 and PPARG2 genes in risk prediction of cataract among North Indian population.

Abbas S, Raza ST, Chandra A, Singh L, Rizvi S, Eba A, Ahmed F, Mahdi F.

Meta Gene. 2014 Apr 17;2:307-13. doi: 10.1016/j.mgene.2014.02.002. eCollection 2014 Dec.

9.

Variation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes.

Black MH, Wu J, Takayanagi M, Wang N, Taylor KD, Haritunians T, Trigo E, Lawrence JM, Watanabe RM, Buchanan TA, Xiang AH.

J Clin Endocrinol Metab. 2015 Mar;100(3):1187-95. doi: 10.1210/jc.2014-3246. Epub 2015 Jan 13.

10.

Protopanaxatriol, a novel PPARγ antagonist from Panax ginseng, alleviates steatosis in mice.

Zhang Y, Yu L, Cai W, Fan S, Feng L, Ji G, Huang C.

Sci Rep. 2014 Dec 9;4:7375. doi: 10.1038/srep07375.

11.

Genome-wide linkage scan identifies two novel genetic loci for coronary artery disease: in GeneQuest families.

Gao H, Li L, Rao S, Shen G, Xi Q, Chen S, Zhang Z, Wang K, Ellis SG, Chen Q, Topol EJ, Wang QK.

PLoS One. 2014 Dec 8;9(12):e113935. doi: 10.1371/journal.pone.0113935. eCollection 2014.

12.

Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer.

Sebio A, Gerger A, Matsusaka S, Yang D, Zhang W, Stremitzer S, Stintzing S, Sunakawa Y, Yamauchi S, Ning Y, Fujimoto Y, Ueno M, Lenz HJ.

Pharmacogenet Genomics. 2015 Jan;25(1):30-7. doi: 10.1097/FPC.0000000000000101.

PMID:
25379721
13.

The Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor Gamma Gene Modifies the Association of Physical Activity and Body Mass Changes in Polish Women.

Zarebska A, Jastrzebski Z, Cieszczyk P, Leonska-Duniec A, Kotarska K, Kaczmarczyk M, Sawczuk M, Maciejewska-Karlowska A.

PPAR Res. 2014;2014:373782. doi: 10.1155/2014/373782. Epub 2014 Oct 13.

14.

c-Abl tyrosine kinase promotes adipocyte differentiation by targeting PPAR-gamma 2.

Keshet R, Bryansker Kraitshtein Z, Shanzer M, Adler J, Reuven N, Shaul Y.

Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16365-70. doi: 10.1073/pnas.1411086111. Epub 2014 Nov 3.

15.

Multilayered genetic and omics dissection of mitochondrial activity in a mouse reference population.

Wu Y, Williams EG, Dubuis S, Mottis A, Jovaisaite V, Houten SM, Argmann CA, Faridi P, Wolski W, Kutalik Z, Zamboni N, Auwerx J, Aebersold R.

Cell. 2014 Sep 11;158(6):1415-30. doi: 10.1016/j.cell.2014.07.039.

PMID:
25215496
16.

Rare mutations of peroxisome proliferator-activated receptor gamma: frequencies and relationship with insulin resistance and diabetes risk in the mixed ancestry population from South Africa.

Vergotine Z, Kengne AP, Erasmus RT, Yako YY, Matsha TE.

Int J Endocrinol. 2014;2014:187985. doi: 10.1155/2014/187985. Epub 2014 Aug 14.

17.

Peroxisome proliferator-activated receptor gamma (PPARG) modulates free fatty acid receptor 1 (FFAR1) dependent insulin secretion in humans.

Wagner R, Hieronimus A, Lamprinou A, Heni M, Hatziagelaki E, Ullrich S, Stefan N, Staiger H, Häring HU, Fritsche A.

Mol Metab. 2014 Jul 7;3(6):676-80. doi: 10.1016/j.molmet.2014.07.001. eCollection 2014 Sep.

18.

Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 diabetes.

Majithia AR, Flannick J, Shahinian P, Guo M, Bray MA, Fontanillas P, Gabriel SB; GoT2D Consortium; NHGRI JHS/FHS Allelic Spectrum Project; SIGMA T2D Consortium; T2D-GENES Consortium, Rosen ED, Altshuler D.

Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13127-32. doi: 10.1073/pnas.1410428111. Epub 2014 Aug 25. Erratum in: Proc Natl Acad Sci U S A. 2014 Nov;11;111(45):16225. Estrada, Karol [added]; Mercader, Josep [added]; MacArthur, Daniel [added].

19.

Polymorphisms of peroxisome proliferator-activated receptors and survival of lung cancer and upper aero-digestive tract cancers.

Yang Y, Burke RV, Jeon CY, Chang SC, Chang PY, Morgenstern H, Tashkin DP, Mao J, Cozen W, Mack TM, Rao J, Zhang ZF.

Lung Cancer. 2014 Sep;85(3):449-56. doi: 10.1016/j.lungcan.2014.06.014. Epub 2014 Jun 27.

PMID:
25043640
20.

CMHX008, a novel peroxisome proliferator-activated receptor γ partial agonist, enhances insulin sensitivity in vitro and in vivo.

Ming Y, Hu X, Song Y, Liu Z, Li J, Gao R, Zhang Y, Mei H, Guo T, Xiao L, Wang B, Wu C, Xiao X.

PLoS One. 2014 Jul 8;9(7):e102102. doi: 10.1371/journal.pone.0102102. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk